Avita Medical (RCEL)
(Real Time Quote from BATS)
$9.54 USD
-0.13 (-1.34%)
Updated Jul 22, 2024 11:12 AM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RCEL 9.54 -0.13(-1.34%)
Will RCEL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for RCEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RCEL
Avita (RCEL) Falls 19% on Lowered 2023 Revenue Guidance
Strength Seen in Avita Medical Inc. (RCEL): Can Its 20.4% Jump Turn into More Strength?
RCEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
AVITA (RCEL) Gets FDA Nod for Expanded Use of RECELL System
Here's Why Momentum in Avita Medical Inc. (RCEL) Should Keep going
Indaptus (INDP) Surges on Upbeat Pre-Clinical Decoy Data
Other News for RCEL
AVITA Medical to Announce Second Quarter 2024 Financial Results
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
Avita Medical Shareholders Support Leadership and Strategy
AVITA Medical Achieves Milestone with First Case Using RECELL GO
Commit To Buy AVITA Medical At $7.50, Earn 81.1% Annualized Using Options